Healthtech startup Tvaster Genkalp raises $1.25 M led by Ideaspring Capital.
Chennai-based Molecular Diagnostics company Tvaster Genkalp has raised USD 1.25 million in a Pre-Series A round led by Ideaspring Capital. The round also saw participation from Invigo Softwares and others.The new funds will be used by the company for expansion and marketing its new product Episcreen Liver.Co-Founded in 2021 by Dr. Srikar Raman and K. Sreedurgalakshmi, Tvaster Genkalp is a Molecular Diagnostics company specialising in Liquid Biopsy and blood based cancer diagnostic solutions which aims to enhance early cancer detection. Episcreen Liver is claimed to detect liver cancer early with 90% accuracy.
Want to receive such news items in your inbox? Click Here to sign up for a trial.